Webinar September 9th 2025 Hannah Douglass: Psilocybin-Therapy for Anorexia Nervosa – Clinical Outcomes and Moderators of Response

When explaining the therapeutic effects of psychedelics, their potential for facilitating changes in deeply ingrained patterns of thought and behaviour is often mentioned as a key ingredient. This is part of the rationale for why there’s increasing interest in investigating whether psychedelics can be useful for treating eating disorders.

In our next webinar lecture, held on Tuesday September 9th at 9AM UTC+3, postdoc researcher Hannah Douglass will outline the existing evidence for the use of psychedelics therapeutically in the treatment of eating disorders, and explore the findings of her PhD work. Specifically, the lecture will focus on whether psilocybin was a safe and feasible intervention in women with anorexia nervosa, whether it was therapeutically beneficial, and the moderators of this response.

The event contains a Q&A section and the total length is 2 hours. Please note the atypical starting time for the webinar – our lecturer resides in New Zealand, which in Finnish time means that we’ll be starting at nine in the morning!

We offer this webinar as a pay what you can event: you can participate without paying, but by paying, you can help us produce more events like this and ensure that we can keep offering them to people regardless of their financial circumstances.

0 € – register here
5–20 € – buy ticket here

If you pay for the ticket, please also remember to register for the webinar via the registration link!

You can also support us by paying our membership fee for 2025. You’ll find our membership products on the main page of our web store. We also accept donations.

About the speaker:

Dr Hannah Douglass is a Postdoctoral Fellow at the University of Auckland where she is working on an LSD microdosing study for mild-moderate depression. She also holds an Honorary Research Associate role at Imperial College London, where she is finalising her doctoral work investigating psilocybin as a treatment for adult females with anorexia nervosa. Hannah is particularly interested in the potential effects of psychedelics on eating behaviours and body dissatisfaction in women’s health conditions and the potential for these compounds to induce neuroplasticity, which she plans to explore further with her team in Auckland.